Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation - PubMed (original) (raw)
Affiliations
- PMID: 14757847
Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation
Daniel J Weisenberger et al. Mol Cancer Res. 2004 Jan.
Abstract
Several alternatively spliced variants of DNA methyltransferase (DNMT) 3b have been described. Here, we identified new murine Dnmt3b mRNA isoforms and found that mouse embryonic stem (ES) cells expressed only Dnmt3b transcripts that contained exons 10 and 11, whereas the Dnmt3b transcripts in somatic cells lacked these exons, suggesting that this region is important for embryonic development. DNMT3b2 and 3b3 were the major isoforms expressed in human cell lines and the mRNA levels of these isoforms closely correlated with their protein levels. Although DNMT3b3 may be catalytically inactive, it still may be biologically important because D4Z4 and satellites 2 and 3 repeat sequences, all known DNMT3b target sequences, were methylated in cells that predominantly expressed DNMT3b3. Treatment of cells with the mechanism-based inhibitor 5-aza-2'-deoxycytidine (5-Aza-CdR) caused a complete depletion of DNMT1, 3a, 3b1, and 3b2 proteins. Human DNMT3b3 and the murine Dnmt3b3-like isoform, Dnmt3b6, were also depleted although less efficiently, suggesting that DNMT3b3 also may be capable of DNA binding. Moreover, de novo methylation of D4Z4 in T24 cancer cells after 5-Aza-CdR treatment only occurred when DNMT3b3 was expressed, reinforcing its role as a contributing factor of DNA methylation. The expression of either DNMT3b2 or 3b3, however, was not sufficient to explain the abnormal methylation of DNMT3b target sequences in human cancers, which may therefore be dependent on factors that affect DNMT3b targeting. Methylation analyses of immunodeficiency, chromosomal instabilities, and facial abnormalities cells revealed that an Alu repeat sequence was highly methylated, suggesting that Alu sequences are not DNMT3b targets.
Similar articles
- De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-deoxycytidine.
Oka M, Meacham AM, Hamazaki T, Rodić N, Chang LJ, Terada N. Oka M, et al. Oncogene. 2005 Apr 28;24(19):3091-9. doi: 10.1038/sj.onc.1208540. Oncogene. 2005. PMID: 15735669 - Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells.
Hattori N, Abe T, Hattori N, Suzuki M, Matsuyama T, Yoshida S, Li E, Shiota K. Hattori N, et al. Genome Res. 2004 Sep;14(9):1733-40. doi: 10.1101/gr.2431504. Epub 2004 Aug 12. Genome Res. 2004. PMID: 15310660 Free PMC article. - The inactive Dnmt3b3 isoform preferentially enhances Dnmt3b-mediated DNA methylation.
Zeng Y, Ren R, Kaur G, Hardikar S, Ying Z, Babcock L, Gupta E, Zhang X, Chen T, Cheng X. Zeng Y, et al. Genes Dev. 2020 Nov 1;34(21-22):1546-1558. doi: 10.1101/gad.341925.120. Epub 2020 Oct 1. Genes Dev. 2020. PMID: 33004415 Free PMC article. - DNMT3B Functions: Novel Insights From Human Disease.
Gagliardi M, Strazzullo M, Matarazzo MR. Gagliardi M, et al. Front Cell Dev Biol. 2018 Oct 22;6:140. doi: 10.3389/fcell.2018.00140. eCollection 2018. Front Cell Dev Biol. 2018. PMID: 30406101 Free PMC article. Review. - DNA methylation and drug resistance in variants of C3H10T1/2 C1 8 cells.
Michalowsky LA, Jones PA. Michalowsky LA, et al. Prog Clin Biol Res. 1986;226:391-9. Prog Clin Biol Res. 1986. PMID: 2433698 Review. No abstract available.
Cited by
- Folate network genetic variation, plasma homocysteine, and global genomic methylation content: a genetic association study.
Wernimont SM, Clark AG, Stover PJ, Wells MT, Litonjua AA, Weiss ST, Gaziano JM, Tucker KL, Baccarelli A, Schwartz J, Bollati V, Cassano PA. Wernimont SM, et al. BMC Med Genet. 2011 Nov 21;12:150. doi: 10.1186/1471-2350-12-150. BMC Med Genet. 2011. PMID: 22103680 Free PMC article. - Expression of DNA Methyltransferase 3B Isoforms Is Associated with DNA Satellite 2 Hypomethylation and Clinical Prognosis in Advanced High-Grade Serous Ovarian Carcinoma.
Del Castillo Falconi VM, Díaz-Chávez J, Torres-Arciga K, Luna-Maldonado F, Gudiño-Gomez AA, Pedroza-Torres A, Castro-Hernández C, Cantú de León D, Herrera LA. Del Castillo Falconi VM, et al. Int J Mol Sci. 2022 Oct 22;23(21):12759. doi: 10.3390/ijms232112759. Int J Mol Sci. 2022. PMID: 36361550 Free PMC article. - Keloid research: current status and future directions.
Tsai CH, Ogawa R. Tsai CH, et al. Scars Burn Heal. 2019 Aug 19;5:2059513119868659. doi: 10.1177/2059513119868659. eCollection 2019 Jan-Dec. Scars Burn Heal. 2019. PMID: 31452957 Free PMC article. Review. - ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation.
Ehrlich M, Sanchez C, Shao C, Nishiyama R, Kehrl J, Kuick R, Kubota T, Hanash SM. Ehrlich M, et al. Autoimmunity. 2008 May;41(4):253-71. doi: 10.1080/08916930802024202. Autoimmunity. 2008. PMID: 18432406 Free PMC article. Review. - Using human disease mutations to understand de novo DNA methyltransferase function.
Rolls W, Wilson MD, Sproul D. Rolls W, et al. Biochem Soc Trans. 2024 Oct 30;52(5):2059-2075. doi: 10.1042/BST20231017. Biochem Soc Trans. 2024. PMID: 39446312 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials